CLINICAL_TRIALS
trial_result
· 2022-02-16
Clinical Trial Update: Detection of False Positives From First-trimester Preeclampsia Screening (StopPRE) at the Second-trimester of Pregnancy [Phase 3]
Summary
Phase 3 clinical trial evaluating false-positive detection from first-trimester preeclampsia screening when applied at the second trimester.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Pre-Eclampsia | Phase 3 | Status: COMPLETED